Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome

被引:3
作者
Bardou-Jacquet, Edouard [1 ,2 ,3 ]
Laine, Fabrice [1 ,3 ]
Morcet, Jeff [3 ]
Perrin, Michele [3 ]
Guyader, Dominique [1 ,2 ,4 ]
Deugnier, Yves [1 ,2 ,3 ,4 ]
机构
[1] CHU Rennes, Liver Unit, F-35033 Rennes, France
[2] Pontchaillou Hosp, INSERM, U991, Rennes, France
[3] Pontchaillou Hosp, INSERM, CIC 0203, Rennes, France
[4] Univ Rennes 1, UFR Med, Rennes, France
关键词
bloodletting; metabolic syndrome; nonalcoholic fatty liver disease; phlebotomy; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HFE MUTATIONS; DEPLETION;
D O I
10.1097/MEG.0000000000000058
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundInitial venesection therapy in dysmetabolic iron overload syndrome (DIOS) was shown to improve insulin resistance. However, no data are available on the long-term outcome of iron store, thus questioning the relevance of maintenance therapy.AimThe aim of the study was to describe the long-term evolution of iron overload after successful iron removal in patients with DIOS.Patients and methodsPatients diagnosed with DIOS from 1998 to 2003 and having completed venesection therapy were proposed an outpatient visit in 2009. Inclusion criteria were as follows: confirmation of the DIOS diagnosis, absence of iron-related treatment or bloodletting since the end of the initial venesection treatment, at least 2 years of follow-up since last phlebotomy. Clinical and biological data were recorded at diagnosis and at inclusion.ResultsA total of 58 patients were included. The mean liver iron content at diagnosis was 8043 mu mol/g and the mean amount of iron removed was 2.2 +/- 1.2 g. The mean follow-up time was 71 +/- 23 months since end of treatment. At inclusion, 64% of patients had recurrence of iron overload. Serum ferritin at diagnosis was the only parameter associated with recurrence of iron overload.ConclusionIn patients with DIOS, the course of iron loading after initial iron removal supports periodical follow-up to detect those patients with recurrence of iron overload who could benefit from maintenance therapy.
引用
收藏
页码:418 / 421
页数:4
相关论文
共 20 条
[1]   Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease [J].
Aigner, Elmar ;
Theurl, Igor ;
Haufe, Heike ;
Seifert, Markus ;
Hohla, Florian ;
Scharinger, Ludwig ;
Stickel, Felix ;
Mourlane, Frederic ;
Weiss, Guenter ;
Datz, Christian .
GASTROENTEROLOGY, 2008, 135 (02) :680-688
[2]   Pathways underlying iron accumulation in human nonalcoholic fatty liver disease [J].
Aigner, Elmar ;
Theurl, Igor ;
Theurl, Milan ;
Lederer, Dieter ;
Haufe, Heike ;
Dietze, Otto ;
Strasser, Michael ;
Datz, Christian ;
Weiss, Guenter .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (05) :1374-1383
[3]   Prevalence of body iron excess in the metabolic syndrome [J].
Bozzini, C ;
Girelli, D ;
Olivieri, O ;
Martinelli, N ;
Bassi, A ;
De Matteis, G ;
Tenuti, I ;
Lotto, V ;
Friso, S ;
Pizzolo, F ;
Corrocher, R .
DIABETES CARE, 2005, 28 (08) :2061-2063
[4]   Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target [J].
Dongiovanni, Paola ;
Fracanzani, Anna Ludovica ;
Fargion, Silvia ;
Valenti, Luca .
JOURNAL OF HEPATOLOGY, 2011, 55 (04) :920-932
[5]   Serum ferritin as a component of the insulin resistance syndrome [J].
Fernández-Real, JM ;
Ricart-Engel, W ;
Arroyo, E ;
Balançá, R ;
Casamitjana-Abella, R ;
Cabrero, D ;
Fernández-Castañer, M ;
Soler, J .
DIABETES CARE, 1998, 21 (01) :62-68
[6]   HFE mutations in insulin resistance-associated hepatic iron overload [J].
Guillygomarc'h, A ;
Mendler, MH ;
Moirand, R ;
Jouanolle, AM ;
David, V ;
Deugnier, Y .
JOURNAL OF HEPATOLOGY, 2000, 33 (03) :515-516
[7]   Venesection therapy of insulin resistance-associated hepatic iron overload [J].
Guillygomarc'h, A ;
Mendler, MH ;
Moirand, R ;
Lainé, F ;
Quentin, V ;
David, V ;
Brissot, P ;
Deugnier, Y .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :344-349
[8]   Insulin resistance-associated hepatic iron overload [J].
Mendler, MH ;
Turlin, B ;
Moirand, R ;
Jouanolle, AM ;
Sapey, T ;
Guyader, D ;
Le Gall, JY ;
Brissot, P ;
David, V ;
Deugnier, Y .
GASTROENTEROLOGY, 1999, 117 (05) :1155-1163
[9]   A new syndrome of liver iron overload with normal transferrin saturation [J].
Moirand, R ;
Mortaji, AM ;
Loreal, O ;
Paillard, F ;
Brissot, P ;
Deugnier, Y .
LANCET, 1997, 349 (9045) :95-97
[10]   HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis [J].
Nelson, James E. ;
Bhattacharya, Renuka ;
Lindor, Keith D. ;
Chalasani, Naga ;
Raaka, Stuart ;
Heathcote, E. Jenny ;
Miskovsky, Emil ;
Shaffer, Eldon ;
Rulyak, Stephen J. ;
Kowdley, Kris V. .
HEPATOLOGY, 2007, 46 (03) :723-729